Caris Life Sciences

Update in progress

CAI (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Caris Life Sciences is an AI-driven biotech company providing molecular profiling services globally. It uses AI/ML to transform healthcare from molecular data. Its platforms include MI Profile (tissue WES/WTS), Caris Assure (blood WES/WTS), Precision Whole Genome (WGS), Caris Detect (multi-cancer early detection), WGS MRD, and ChromoSeq for hematologic cancers. It also offers pharma R&D services. Founded 2008, Irving, Texas.

Company score

Sentiment: 0.36; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.19; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.08; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.07; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.21; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive